We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Language Barrier Leads to Prescription Errors

By HospiMedica staff writers
Posted on 22 May 2007
Patients who have only a limited understanding of English, or none at all, are at a serious risk of medication errors, claims a new study.

Researchers at The New York Academy of Medicine (NY, USA) randomly selected 200 pharmacies from the 2,186 licensed pharmacies in New York City (NY, USA) in 2006. More...
Participating pharmacies included independent drugstores, chains, and outpatient hospital and clinic pharmacies. The researchers found that while 88% of surveyed New York City pharmacists reported serving limited English-proficient (LEP) customers daily, only 34% reported translating labels daily, despite 80% reporting the ability to do so. Another 26% never translate labels. Fewer than 10% of pharmacies reported posted signs to inform customers that translated labels are available.

Pharmacists cited a number of barriers to improved language access, including the need for additional translation tools (24%) and bilingual personnel (20%). Five percent cited legal concerns; specifically, they fear being held liable if they print medication information in a language that they do not understand and fail to spot a flawed translation. Others cited time (7%) and cost (7%) constraints. The study was presented at the annual meeting of the Society for General Internal Medicine (SGIM) held during April 2007 in Toronto (Ontario, Canada).

"Imagine, as an English speaker, picking up a prescription with a label in Chinese--you have no idea what it says. Many New York immigrants face such high-risk gaps in our health-care services when presented with a medication bottle in English,” said lead author Linda Weiss, Ph.D,. "New York City pharmacies would engage in good health and business practices by providing labels and health counseling in languages their patients understand.”


Related Links:
The New York Academy of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.